Literature DB >> 15291019

The impact of minimally invasive cervical spine surgery. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.

Tim E Adamson1.   

Abstract

Since 1997, cervical endoscopic laminoforaminotomy (CELF) has been an effective and safe treatment option for unilateral cervical radiculopathy secondary to disc herniation or foraminal stenosis. The development of the surgical technique is reviewed and recent outcomes discussed. Its impact is addressed in relation to the patient and surgeon.

Entities:  

Mesh:

Year:  2004        PMID: 15291019     DOI: 10.3171/spi.2004.1.1.0043

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  5 in total

1.  Morphometric study of the nerve roots around the lateral mass for posterior foraminotomy.

Authors:  Jae-Chan Hwang; Hak-Geun Bae; Sung-Won Cho; Sung-Jin Cho; Hyung-Ki Park; Jae-Chil Chang
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

2.  Posterior cervical inclinatory foraminotomy for spondylotic radiculopathy preliminary.

Authors:  Jae-Chil Chang; Hyung-Ki Park; Soon-Kwan Choi
Journal:  J Korean Neurosurg Soc       Date:  2011-05-31

3.  Minimally invasive tubular access for posterior cervical foraminotomy.

Authors:  Byron C Branch; Donald L Hilton; Clark Watts
Journal:  Surg Neurol Int       Date:  2015-05-19

4.  Morphology of Herniated Disc as a Predictor for Outcomes of Posterior Percutaneous Full-endoscopic Cervical Discectomy in Treating Cervical Spondylotic Radiculopathy.

Authors:  Yi Liu; Guo-Ke Tang; Wei-Heng Wang; Chang-Gui Shi; Shuang Wang; Lei Yu; Jiang-Ming Yu; Xiao-Jian Ye
Journal:  Orthop Surg       Date:  2021-11-09       Impact factor: 2.071

5.  Comparison of one-level microendoscopy laminoforaminotomy and cervical arthroplasty in cervical spondylotic radiculopathy: a minimum 2-year follow-up study.

Authors:  Guo Min Liu; Ya Jun Wang; Dong Sheng Wang; Qin-Yi Liu
Journal:  J Orthop Surg Res       Date:  2013-12-17       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.